A recent study suggests that patients who come off popular GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who halt conventional lifestyle plans.
Published data in a prominent medical journal points out that while overweight people can lose substantial amounts of their total mass while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month after stopping.
"Individuals buying such drugs should be informed of the danger of quick rebound weight gain when the treatment concludes," cautioned researcher Dr. Susan Jebb.
This pace of recovery suggests a reversion to pre-treatment weight in about one and a half years.
Comparing Approaches
The research, which reviewed dozens of trials involving thousands of patients, contrasted the outcomes of the injectable medications with other pills.
Researchers note that people who shed pounds through diet and exercise generally see a more gradual creep back—approximately 0.1 kg a month—post-intervention.
Understanding the Quick Rebound
Experts propose the mechanism of the injections explains the amplified rebound.
These medications copy a natural hormone called GLP-1, which controls hunger.
"Long-term administration of the hormone levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its endogenous hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Stopping of this GLP-1 'fix' means hunger is no longer kept in check, making binge eating far more likely."
A Lifelong Condition?
The NHS recommend the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
Many experts say that, given the high risk of weight regain, the treatment should be considered long-term.
This opinion is reinforced by pharmaceutical companies, who say that the findings "highlight the long-term character of obesity," similar to managing conditions like high blood pressure.
Patient Testimonies
Users who have come off the medication describe a intense return of cravings.
"It felt as if a trigger activating and you're instantly ravenous," recalled one woman.
This challenge is compounded if patients have not developed lasting dietary or behavioural changes during therapy.
Significant Use
Recent estimates show that millions of people in the UK have tried these injections in the last 12 months, with interest continuing to grow.
- Use is greater among women compared to men.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
Finally, clinicians stress that while the jabs are powerful tools for shedding pounds, they are not a magic solution and lasting health benefits relies on ongoing lifestyle changes.
